Percutaneous Coronary Intervention

In patients with anemia who present with MI, a restrictive blood transfusion strategy was noninferior to liberal transfusion for preventing major adverse CV events at 30 days, according to results of the REALITY trial.

In patients who underwent PCI, trimetazidine, a drug to improve myocardial metabolism, did not improve angina recurrence or other CV outcomes, according to results of the ATPCI trial presented at the European Society of Cardiology Congress.

Despite the greater risk for mortality, elective PCI for veterans with stable angina performed at community care centers rather than integrated Veterans Affairs health care centers increased from 2015 to 2018, researchers reported.

Among patients with acute MI, cardiogenic shock and multivessel CAD, multivessel PCI was associated with elevated risk for in-hospital complications and mortality compared with culprit-lesion-only PCI, researchers reported.

Patients who underwent IVUS-guided PCI had more comorbidities but experienced less mortality, MI and repeat revascularization during the follow-up period than patients who underwent PCI without IVUS, researchers reported.

Philips announced it has launched a solid core pressure wire for use in coronary artery interventional procedures after the wire received FDA clearance.

Boston Scientific announced that its bioabsorbable polymer stent platform has received a new indication from the FDA to treat patients at high bleeding risk.

YouTube was found to be an effective tool for educating patients who had PCI for MI on their condition and the significance of adherence to their prescribed dual antiplatelet therapy, researchers reported.

Inhibition of platelet aggregation using different regiments in patients with STEMI undergoing PCI.

Optimal techniques for stenting complex coronary bifurcation lesions.